|
Delayed
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | -99.33% |
| 08-06 | Morphic Medical Announces Board Appointments, Effective August 6, 2026 | CI |
| 08-03 | Morphic Medical Inc. Provides Update On Reset System Clinical And Commercial Progress | CI |
| Market Cap | 440K 395K 364K 329K 616K 41.95M 626K 4.34M 1.73M 21.95M 1.65M 1.62M 69.53M | P/E 2019 |
-1.12x | P/E 2020 | -0.03x |
|---|---|---|---|---|---|
| Enterprise Value | 3.28M 2.94M 2.71M 2.45M 4.59M 312M 4.66M 32.33M 12.9M 163M 12.31M 12.05M 518M | EV / Sales 2019 |
-
| EV / Sales 2020 | - |
| Free-Float |
-
| Yield 2019 * |
-
| Yield 2020 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mike Gutteridge
CEO | Chief Executive Officer | - | 05/08/2025 |
Jane Wright
DFI | Director of Finance/CFO | 57 | 01/08/2025 |
| Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Ginger Glaser
BRD | Director/Board Member | - | 20/10/2020 |
Alex Escalona
BRD | Director/Board Member | - | - |
John R. Barr
BRD | Director/Board Member | 69 | 01/10/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/01/21 | Free | Chairman | 1,384,483 | 0.4875% | ||
| 28/01/21 | Free | Chief Executive Officer | 11,075,869 | 3.8998% |
| 2019 | 2020 | |
|---|---|---|
| Net sales | - | - |
| Net income | -17.33M -15.53M -14.32M -12.96M -24.24M -1.65B -24.63M -171M -68.17M -864M -65.05M -63.66M -2.74B | -11.14M -9.97M -9.2M -8.33M -15.57M -1.06B -15.82M -110M -43.8M -555M -41.79M -40.9M -1.76B |
| Net Debt | 2.89M 2.59M 2.39M 2.16M 4.04M 275M 4.1M 28.46M 11.35M 144M 10.83M 10.6M 456M | 2.84M 2.54M 2.35M 2.12M 3.97M 270M 4.03M 27.99M 11.17M 141M 10.65M 10.43M 448M |
Employees
-
Sector
-
- Stock Market
- Stocks
- GIDYL Stock
Select your edition
All financial news and data tailored to specific country editions
















